NEW YORK (GenomeWeb News) - A Japan-based proteomics collaboration will use Genedata’s software in its search for metastatic biomarkers, the company said today.
The collaborators, including Tokyo Medical University, AMR, and Leica Microsystems, will use the Genedata Expressionist software to handle data from mass-spectrometry proteomics research, Genedata said.
The project is focused on finding and validating new protein drug targets using lung and endocrine carcinoma samples taken from formalin-fixed paraffin-embedded tissue collections.
Financial terms of the agreement were not released.